feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / FDA May Loosen Supplement Warning Labels

FDA May Loosen Supplement Warning Labels

16 Dec, 2025

•

Summary

  • FDA considers reducing frequency of supplement warning labels.
  • Experts fear weakened warnings could mislead consumers.
  • Nearly 9 out of 10 melatonin brands had inaccurate labels.
FDA May Loosen Supplement Warning Labels

The Food and Drug Administration is contemplating a revision to its regulations that would decrease the mandatory display frequency of warning labels on dietary supplement packaging. This proposed alteration could potentially make these important disclaimers less visible to consumers, raising concerns among health experts.

Currently, federal law mandates that supplement packaging include a disclaimer, such as "This statement has not been evaluated by the Food and Drug Administration," whenever health claims are made. The FDA acknowledges that enforcement of this rule has been infrequent and suggests the change would reduce label clutter and costs for manufacturers.

Critics argue that weakening these warnings could further obscure the fact that supplements are not subject to pre-market review for safety and efficacy, unlike prescription drugs. Past studies have shown significant labeling inaccuracies, undermining consumer trust and understanding of product contents.

trending

Pakistan India T20 boycott

trending

Qualcomm stock falls on shortages

trending

Bridgerton Season 4 returns

trending

HAL shares tumble after AMCA

trending

Cognizant profit rises 18.7%

trending

Bharat Taxi launches in Delhi

trending

JSW Cement Q3 profit rises

trending

Suzlon Energy Q3 results up

trending

Trent share price cautious outlook

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The FDA is considering reducing the frequency of warnings, not eliminating them entirely. They would still be required at least once on the packaging.
The FDA cited reducing label clutter and costs for manufacturers as reasons, noting infrequent enforcement of the current rule.
Experts worry that less prominent warnings could make it harder for consumers to notice potential issues, especially since supplements aren't FDA-reviewed before market.

Read more news on

Healthside-arrow

You may also like

ByHeart Formula: Years of Contamination Feared

11 Dec, 2025 • 339 reads

article image

FDA Approves Home-Use Device for Depression Treatment

12 Dec, 2025 • 219 reads

article image

Ex-FDA Chiefs Slam Agency's Vaccine Safety Doubts

4 Dec, 2025 • 327 reads

article image

FDA Warns: Toxic Lead in Kitchenware!

2 Dec, 2025 • 395 reads

article image

New Glasses Slow Kids' Nearsightedness

1 Dec, 2025 • 360 reads